Delivery Order SPE2DB22D2206-SPE2DB25FFL69

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,772.40, is for the delivery of FLUCYTOSINE 500 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 31, 2024. The award is not designated as a set-aside contract. It is associated with a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,905,008 units of Flucytosine 500 mg capsules. The contract has a ceiling value of $21,681.33 and a period of performance through March 11, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Flucytosine 500 mg capsules. The $1,703.42 firm fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,239.04 contract provides for the delivery of 4,567,192,930 units of the pharmaceutical product FLUCYTOSINE 500 MG CAPSULE UD 30S. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,460.21, is for the supply of Fluorouracil 5% Cream 40GM, a pharmaceutical product. The contract is a firm-fixed-price delivery order, with an ultimate completion date of January 7, 2025. This contract does not have a set-aside designation, indicating it was awarded through open competition....
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.10, is a Delivery Order contract for the supply of XOFLUZA 80 MG TABLET. The contract has a firm fixed price and an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,264.44 firm fixed-price contract is for the supply of 4,565,441,631 units of the generic pharmaceutical Fluconazole 150 mg tablets. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide essential medical commodities, including...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,356.89, is a Delivery Order with a Firm Fixed Price pricing type and a completion date of February 12, 2025. The award is for the supply of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,465.19 firm fixed-price delivery order is for the supply of 4,566,449,747 units of FOSCARNET 6,000 MG/250 ML BTTL 250ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. There was no set-aside designation for this contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,549.72 firm-fixed-price delivery order covers the supply of Fluorouracil 0.5% Cream, a specialty medication used for various medical conditions. The award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFL69
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of FLUCYTOSINE 500 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a ceiling value of $11,630.71 and a completion date of February 6, 2025.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a specific set-aside requirement, indicating open competition.

Generated 5/7/25, 9:58 AM